Jerome Samson

A few words about me

Academics

• University of Paris V: René Descartes, 2001-2005 ([1]), PhD in Pharmaceutical Sciences

• Ecole Polytechnique, 1997-2000 ([2]), Engineer degree

Work

• Seventure Partners, 2007-, Venture capital firm, Associate

• Sofinnova Partners, 2006, Venture capital firm, Analyst

• The Boston Consulting Group, 2005-2006, Management consulting, Senior Associate

Further details can be found on my webpage.

My personal interests

• Biology: aptamer
• Biotechnology: metabolic engineering
• Business: Boston Consulting Group, Venture Capital, Biotechnology startups
• Offshore Sailing: Transatlantic cruise in Jan. 2007, Class 40 sailing boats
• Scuba diving
• Running: half marathon

My Publications

• Kertesz N, Samson J, Debacker C, Wu H and Labastie MC, Cloning and characterization of human and mouse SNRK sucrose non-fermenting protein (SNF-1)-related kinases, Gene, 294(1-2):13-24, 2002 PMID:12234663
• Garbay C, Gigoux V, Camonis J, L'Hoste S, Samson J, Methods to identify anti-tumoral agents inhibiting RasGAP / Aurora Kinase interactions, Patent Application WO03087395, 2003
• Pamonsinlapatham P, Hadj-Slimane R, Raynaud F, Bickle M, Corneloup C, Barthelaix A, Lepelletier Y, Mercier P, Schapira M, Samson J, Mathieu AL, Hugo N, Moncorgé O, Mikaelian I, Dufour S, Garbay C, Colas P. A RasGAP SH3 peptide aptamer inhibits RasGAP-Aurora interaction and induces caspase-independent tumor cell death, PLoS One, 3(8):e2902, 2008. PMID:18682833

Selected external links

• Aptanomics
• The Boston Consulting Group

Wikipedia:Babel

frCet utilisateur a pour langue maternelle le français.

en-4This user can contribute with a near-native level of English.

de-1Dieser Benutzer hat grundlegende Deutschkenntnisse.

Search user languages